Literature DB >> 1563788

Mouse antibody to phosphocholine can protect mice from infection with mouse-virulent human isolates of Streptococcus pneumoniae.

D E Briles1, C Forman, M Crain.   

Abstract

Previous studies have demonstrated that mouse antibodies to phosphocholine (PC) can protect mice against fatal infection caused by several, but not all, mouse-virulent laboratory strains of Streptococcus pneumoniae. Because the pneumococcal strains used in previous studies had been mouse passed and were propagated for many years outside of humans, it was not known whether antibody to PC would be able to protect mice against S. pneumoniae freshly isolated from humans. In the present study, we examined the ability of an immunoglobulin G (IgG) monoclonal antibody (MAb) to PC to protect against infections in mice caused by 14 pneumococcal strains of capsular types 3, 4, 6A, and 6B. Nine of these strains were selected as the most virulent strains for mice from a group of 69 fresh clinical isolates. Five were mouse-passed laboratory strains. Mouse IgG3 MAb to PC was able to exhibit protective effects (survival or increased time to death) against infection with virtually all of the strains injected intravenously and against infection with 70% of the strains injected intraperitoneally. The protective effects of antibody to PC appeared to be partially dependent on capsular type. MAb to PC was most effective against capsular type 3 strains and least effective against type 4 strains. With type 3 and type 4 strains, MAb to PC could frequently protect against larger numbers of CFU injected intravenously than intraperitoneally. For capsular type 6A and 6B strains the reverse was true.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1563788      PMCID: PMC257101          DOI: 10.1128/iai.60.5.1957-1962.1992

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  38 in total

1.  PNEUMOCOCCAL BACTEREMIA WITH ESPECIAL REFERENCE TO BACTEREMIC PNEUMOCOCCAL PNEUMONIA.

Authors:  R AUSTRIAN; J GOLD
Journal:  Ann Intern Med       Date:  1964-05       Impact factor: 25.391

2.  Strong association between capsular type and virulence for mice among human isolates of Streptococcus pneumoniae.

Authors:  D E Briles; M J Crain; B M Gray; C Forman; J Yother
Journal:  Infect Immun       Date:  1992-01       Impact factor: 3.441

3.  Purification and immunogenicity of genetically obtained pneumolysin toxoids and their conjugation to Streptococcus pneumoniae type 19F polysaccharide.

Authors:  J C Paton; R A Lock; C J Lee; J P Li; A M Berry; T J Mitchell; P W Andrew; D Hansman; G J Boulnois
Journal:  Infect Immun       Date:  1991-07       Impact factor: 3.441

4.  A protective monoclonal antibody that reacts with a novel antigen of pneumococcal teichoic acid.

Authors:  L S McDaniel; W D Waltman; B Gray; D E Briles
Journal:  Microb Pathog       Date:  1987-10       Impact factor: 3.738

5.  The role of antibodies to pneumococcal C polysaccharide in otitis media.

Authors:  J Henrichsen; C H Sørensen
Journal:  Pediatr Infect Dis J       Date:  1989-01       Impact factor: 2.129

6.  Pneumococcal surface protein A (PspA) is serologically highly variable and is expressed by all clinically important capsular serotypes of Streptococcus pneumoniae.

Authors:  M J Crain; W D Waltman; J S Turner; J Yother; D F Talkington; L S McDaniel; B M Gray; D E Briles
Journal:  Infect Immun       Date:  1990-10       Impact factor: 3.441

Review 7.  Virulence, immunity, and vaccine related to Streptococcus pneumoniae.

Authors:  C J Lee; S D Banks; J P Li
Journal:  Crit Rev Microbiol       Date:  1991       Impact factor: 7.624

8.  The protective efficacy of polyvalent pneumococcal polysaccharide vaccine.

Authors:  E D Shapiro; A T Berg; R Austrian; D Schroeder; V Parcells; A Margolis; R K Adair; J D Clemens
Journal:  N Engl J Med       Date:  1991-11-21       Impact factor: 91.245

9.  Anti-phosphocholine hybridoma antibodies. II. Functional analysis of binding sites within three antibody families.

Authors:  C M Andres; A Maddalena; S Hudak; N M Young; J L Claflin
Journal:  J Exp Med       Date:  1981-11-01       Impact factor: 14.307

10.  Antigen-independent selection of T15 idiotype during B-cell ontogeny in mice.

Authors:  M Vakil; D E Briles; J F Kearney
Journal:  Dev Immunol       Date:  1991
View more
  34 in total

1.  Opsonization of Actinobacillus actinomycetemcomitans by immunoglobulin G antibody reactive with phosphorylcholine.

Authors:  Donald Purkall; John G Tew; Harvey A Schenkein
Journal:  Infect Immun       Date:  2002-11       Impact factor: 3.441

Review 2.  Antibody-mediated immunity against intracellular pathogens: two-dimensional thinking comes full circle.

Authors:  Arturo Casadevall
Journal:  Infect Immun       Date:  2003-08       Impact factor: 3.441

3.  Acquired, but not innate, immune responses to Streptococcus pneumoniae are compromised by neutralization of CD40L.

Authors:  Y i Hwang; M H Nahm; D E Briles; D Thomas; J M Purkerson
Journal:  Infect Immun       Date:  2000-02       Impact factor: 3.441

4.  Differential PsaA-, PspA-, PspC-, and PdB-specific immune responses in a mouse model of pneumococcal carriage.

Authors:  Ravichandran Palaniappan; Shailesh Singh; Udai P Singh; Senthil Kumar K Sakthivel; Edwin W Ades; David E Briles; Susan K Hollingshead; James C Paton; Jacquelyn S Sampson; James W Lillard
Journal:  Infect Immun       Date:  2005-02       Impact factor: 3.441

5.  Pneumococcal capsular polysaccharide vaccine-mediated protection against serotype 3 Streptococcus pneumoniae in immunodeficient mice.

Authors:  Haijun Tian; Avi Groner; Marianne Boes; Liise-anne Pirofski
Journal:  Infect Immun       Date:  2007-01-12       Impact factor: 3.441

6.  Involvement of potD in Streptococcus pneumoniae polyamine transport and pathogenesis.

Authors:  D Ware; Y Jiang; W Lin; E Swiatlo
Journal:  Infect Immun       Date:  2006-01       Impact factor: 3.441

Review 7.  Antibody immunity and invasive fungal infections.

Authors:  A Casadevall
Journal:  Infect Immun       Date:  1995-11       Impact factor: 3.441

8.  Protective humoral response against pneumococcal infection in mice elicited by recombinant bacille Calmette-Guérin vaccines expressing pneumococcal surface protein A.

Authors:  S Langermann; S R Palaszynski; J E Burlein; S Koenig; M S Hanson; D E Briles; C K Stover
Journal:  J Exp Med       Date:  1994-12-01       Impact factor: 14.307

9.  Unique modifications with phosphocholine and phosphoethanolamine define alternate antigenic forms of Neisseria gonorrhoeae type IV pili.

Authors:  Finn Terje Hegge; Paul G Hitchen; Finn Erik Aas; Heidi Kristiansen; Cecilia Løvold; Wolfgang Egge-Jacobsen; Maria Panico; Weng Yee Leong; Victoria Bull; Mumtaz Virji; Howard R Morris; Anne Dell; Michael Koomey
Journal:  Proc Natl Acad Sci U S A       Date:  2004-07-12       Impact factor: 11.205

10.  Genetic and functional analyses of PptA, a phospho-form transferase targeting type IV pili in Neisseria gonorrhoeae.

Authors:  Cecilia L Naessan; Wolfgang Egge-Jacobsen; Ryan W Heiniger; Matthew C Wolfgang; Finn Erik Aas; Asmund Røhr; Hanne C Winther-Larsen; Michael Koomey
Journal:  J Bacteriol       Date:  2007-10-19       Impact factor: 3.490

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.